{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:13:42Z","timestamp":1791915222429,"version":"4.3.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1097\/md.0000000000008148","type":"journal-article","created":{"date-parts":[[2017,9,27]],"date-time":"2017-09-27T16:21:01Z","timestamp":1506529261000},"page":"e8148","source":"Crossref","is-referenced-by-count":24,"title":["Apolipoprotein A-1-related amyloidosis 2 case reports and review of the literature"],"prefix":"10.1097","volume":"96","author":[{"given":"Chunlei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-48-20210309","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-48-20210309","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.19.1.10","article-title":"Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer","volume":"19","author":"Van Allen","year":"1969","journal-title":"Neurology"},{"key":"R3-48-20210309","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0006-291X(88)80909-4","article-title":"Variant apolipoprotein AI as a major constituent of a human hereditary amyloid","volume":"156","author":"Nichols","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"R4-48-20210309","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ajpath.2011.06.024","article-title":"Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I","volume":"179","author":"Rowczenio","year":"2011","journal-title":"Am J Pathol"},{"key":"R5-48-20210309","first-page":"695","article-title":"A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis","volume":"88","author":"Booth","year":"1995","journal-title":"QJM"},{"key":"R6-48-20210309","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1073\/pnas.89.16.7389","article-title":"Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis","volume":"89","author":"Soutar","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-48-20210309","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1172\/JCI118725","article-title":"Hereditary hepatic and systemic amyloidosis caused by a new deletion\/insertion mutation in the apolipoprotein Al gene","volume":"97","author":"Booth","year":"1996","journal-title":"J Clin Invest"},{"key":"R8-48-20210309","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1053\/j.ajkd.2004.08.033","article-title":"Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro","volume":"44","author":"Murphy","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R9-48-20210309","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1523-1755.1998.00770.x","article-title":"Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I","volume":"53","author":"Persey","year":"1998","journal-title":"Kidney Int"},{"key":"R10-48-20210309","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2353\/jmoldx.2009.080161","article-title":"Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene","volume":"11","author":"Eriksson","year":"2009","journal-title":"J Mol Diagn"},{"key":"R11-48-20210309","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1681\/ASN.2005040382","article-title":"Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis","volume":"16","author":"Gregorini","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R12-48-20210309","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9440(10)65268-6","article-title":"Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1","volume":"154","author":"Asl","year":"1999","journal-title":"Am J Pathol"},{"key":"R13-48-20210309","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/bbrc.1997.8005","article-title":"Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation","volume":"242","author":"Amarzguioui","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-48-20210309","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13506129.2015.1077217","article-title":"Amyloid cardiomyopathy associated with a novel apolipoprotein A-I Q172P variant","volume":"22","author":"Vonberg","year":"2015","journal-title":"Amyloid"},{"key":"R15-48-20210309","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/bbrc.1999.0518","article-title":"A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis","volume":"257","author":"Asl","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-48-20210309","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0002-9440(10)65167-X","article-title":"The new apolipoprotein A-I variant Leu(174) -> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide","volume":"155","author":"Obici","year":"1999","journal-title":"Am J Pathol"},{"key":"R17-48-20210309","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0002-9440(10)65064-X","article-title":"Apolipoprotein Al and transthyretin as components of amyloid fibrils in a kindred with apoAl Leu178His amyloidosis","volume":"156","author":"de Sousa","year":"2000","journal-title":"Am J Pathol"},{"key":"R18-48-20210309","first-page":"1013","article-title":"Pulmonary vascular amyloidosis in aged dogs\u2014a new form of spontaneously occurring amyloidosis derived from apolipoprotein AI","volume":"141","author":"Johnson","year":"1992","journal-title":"Am J Pathol"},{"key":"R19-48-20210309","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1002\/art.22201","article-title":"Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I","volume":"54","author":"Solomon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R20-48-20210309","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S","article-title":"Apolipoprotein A-I-derived amyloid in atherosclerotic plaques of the human aorta","volume":"193","author":"Mucchiano","year":"2001","journal-title":"J Pathol"},{"key":"R21-48-20210309","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/mus.23415","article-title":"Mass spectrometry analysis reveals non-mutated apolipoprotein a1 lumbosacral radiculoplexus amyloidoma","volume":"46","author":"Loavenbruck","year":"2012","journal-title":"Muscle Nerve"},{"key":"R22-48-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1050-1738(01)00163-3","article-title":"The effects of altered apolipoprotein A-I structure on plasma HDL concentration","volume":"12","author":"Sorci-Thomas","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"R23-48-20210309","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0022-2275(20)34437-0","article-title":"Proteolytic events affecting plasma apolipoproteins at the co- and post-translational levels and after maturation","volume":"25","author":"Scanu","year":"1984","journal-title":"J Lipid Res"},{"key":"R24-48-20210309","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1074\/jbc.M112.428052","article-title":"Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I destabilization of helix bundle and enhancement of fibril formation","volume":"288","author":"Adachi","year":"2013","journal-title":"J Biol Chem"},{"key":"R25-48-20210309","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"R26-48-20210309","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"R28-48-20210309","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejmg.2016.05.015","article-title":"A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype","volume":"59","author":"Tougaard","year":"2016","journal-title":"Eur J Med Genet"},{"key":"R29-48-20210309","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/febs.12809","article-title":"Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis","volume":"281","author":"Das","year":"2014","journal-title":"FEBS J"},{"key":"R30-48-20210309","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ki.2014.389","article-title":"Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis","volume":"87","author":"Gregorini","year":"2015","journal-title":"Kidney Int"},{"key":"R31-48-20210309","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2012-03-413682","article-title":"How I treat amyloidosis: the importance of accurate diagnosis and amyloid typing","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"key":"R32-48-20210309","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"114","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"R33-48-20210309","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MNH.0b013e3280bdc0db","article-title":"New insights into systemic amyloidosis: the importance of diagnosis of specific type","volume":"16","author":"Picken","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R34-48-20210309","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbadis.2010.07.002","article-title":"The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease","volume":"1812","author":"Marchesi","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R35-48-20210309","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with I-123 labeled serum amyloid-P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"R36-48-20210309","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/j.1600-6143.2006.01507.x","article-title":"Organ transplantation in hereditary apolipoprotein AI amyloidosis","volume":"6","author":"Gillmore","year":"2006","journal-title":"Am J Transplant"},{"key":"R37-48-20210309","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"},{"key":"R38-48-20210309","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:34:47Z","timestamp":1620959687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201709290-00048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008148","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}